cannabis.wine / intel

New York

Last updated July 7, 2026 AI-drafted — pending review

New York regulates hemp-derived cannabinoid products through the Office of Cannabis Management (OCM) under 9 NYCRR Part 114/1005 (Cannabinoid Hemp Program). Intoxicating cannabinoids are prohibited from the hemp framework — delta-8, delta-10, HHC, THCP, THCB, and all synthetic or isomerized cannabinoids are explicitly banned. Beverages are limited to ≤25mg total cannabinoids per package with a single-serving-per-container rule. Intoxicating THC beverages must be sold through OCM-licensed cannabis dispensaries, not hemp retailers.

Status
Blocked
DTC shipping
Permitted for licensed cannabinoid hemp retailers selling compliant products; intoxicating hemp beverages routed to OCM cannabis dispensary channel
Serving cap
Beverages: 1 serving per package (single-can rule); ≤25mg total cannabinoids per product
Container cap
≤25mg total cannabinoids per package for food/beverages; multi-packs (e.g. 6-pack of single-serving cans) permitted
Age gate
21+
License
Required — Cannabinoid Hemp Retail License ($300/location, 1-year); Processor License ($3,500 extracting or $1,000 manufacturing-only, 2-year); GMP audit + product liability insurance required
Regulator
New York State Office of Cannabis Management (OCM) — Cannabinoid Hemp Program; New York Department of Agriculture and Markets — industrial hemp cultivation
Current rule effective
November 22, 2021
Next known change — in 117 days
November 12, 2026 — Federal P.L. 119-37 § 781 takes effect. OCM has published guidance stating New York is already substantially aligned with the federal total-THC standard; limited state adaptation expected.
Federal alignment (P.L. 119-37 § 781)
Stricter than federal New York banned synthetic and intoxicating hemp cannabinoids ahead of federal action. OCM's Nov 2025 FAQ characterizes New York as already substantially aligned with P.L. 119-37 §781 — limited adaptation expected at the Nov 12 cliff.

Retail channels

  • OCM-licensed Cannabinoid Hemp Retailers: non-intoxicating hemp products (CBD, etc.) with ≤25mg total cannabinoids/package
  • OCM-licensed Adult-Use Cannabis Dispensaries: intoxicating THC beverages (regulated separately under MRTA, not the hemp program)
  • Convenience/grocery: prohibited without Cannabinoid Hemp Retail License
  • Online: permitted from licensed retailers for compliant products
  • Prohibited product forms: pre-rolls/cigarettes/cigars, injectables, inhalers, alcohol combinations, synthetic cannabinoids

Statutes & bills cited

  • Marihuana Regulation and Taxation Act (MRTA) — 2021
  • New York Cannabis Law — codified framework
  • 9 NYCRR Part 114 (Cannabinoid Hemp Program regulations)
  • 9 NYCRR §114.8 — cannabinoid hemp product requirements
  • 9 NYCRR §1005.8 — retail product requirements
  • 9 NYCRR §1005.11 — retailer conduct

New York’s approach to hemp-derived cannabinoids is unusually restrictive. The Cannabinoid Hemp Program, established under the 2021 Marihuana Regulation and Taxation Act (MRTA), pushes intoxicating cannabinoids into the state’s licensed adult-use cannabis system rather than allowing them in the hemp retail channel. Delta-8, delta-10, HHC, THCP, THCB, and all cannabinoids created through synthesis or isomerization are explicitly prohibited from cannabinoid hemp products (9 NYCRR §114.8(11), §1005.8). For hemp-derived beverages that comply — meaning CBD-dominant or trace-THC products under the 25mg total cannabinoid cap — sale requires a Cannabinoid Hemp Retail License at $300/location per year, and beverages must be packaged as single servings (though multi-packs of single-serving cans are permitted). Adult-use cannabis dispensaries, licensed separately under MRTA, are the legal channel for intoxicating THC beverages. This structural choice puts New York substantially ahead of the Nov 12, 2026 federal cliff — OCM’s November 2025 guidance FAQ signals limited state-level adaptation will be needed when P.L. 119-37 §781 takes effect.


Discover more from Cannabis.Wine

Subscribe to get the latest posts sent to your email.

This state summary has not yet been reviewed by counsel. Verify with your attorney before making commercial decisions.